2025
The Incremental Risk of Major Amputation With Reinterventions in Patients With Peripheral Arterial Disease
Carter W, Alameddine D, Said S, Aboian E, Tonnessen B, Cardella J, Guzman R, Chaar C. The Incremental Risk of Major Amputation With Reinterventions in Patients With Peripheral Arterial Disease. Journal Of Vascular Surgery 2025, 81: e186-e187. DOI: 10.1016/j.jvs.2025.03.332.Peer-Reviewed Original ResearchPreoperative Smoking Cessation Impacts Presentation and Long-term Neurologic Outcomes of Carotid Endarterectomy
Schwartz A, Carter W, Tonnessen B, Arhuidese I, Cardella J, Dardik A, Guzman R, Chaar C. Preoperative Smoking Cessation Impacts Presentation and Long-term Neurologic Outcomes of Carotid Endarterectomy. Journal Of Vascular Surgery 2025, 81: e185-e186. DOI: 10.1016/j.jvs.2025.03.331.Peer-Reviewed Original ResearchFactors Associated With One-year Functional Decline After Elective Endovascular Abdominal Aortic Aneurysm Repair in Octogenarians
Li J, Bader J, Guzman R, Tonnessen B, Slade M, Gill T, Kuwayama D, Dardik A, Cardella J, Chaar C. Factors Associated With One-year Functional Decline After Elective Endovascular Abdominal Aortic Aneurysm Repair in Octogenarians. Journal Of Vascular Surgery 2025, 81: e138-e140. DOI: 10.1016/j.jvs.2025.03.277.Peer-Reviewed Original ResearchAntithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions
Said S, Alameddine D, Fischer U, Zwibelman H, Kabbani L, Kashyap V, Tonnessen B, Cardella J, Guzman R, Chaar C. Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions. Journal Of Vascular Surgery 2025, 81: e56-e58. DOI: 10.1016/j.jvs.2025.03.124.Peer-Reviewed Original ResearchSmoking Cessation Duration to Decrease the Risk of Amputation After Revascularization for Chronic Limb-Threatening Ischemia
Carter W, Schwartz A, Sumpio B, Strosberg D, Tonnessen B, Cardella J, Guzman R, Chaar C. Smoking Cessation Duration to Decrease the Risk of Amputation After Revascularization for Chronic Limb-Threatening Ischemia. Journal Of Vascular Surgery 2025, 81: e259-e260. DOI: 10.1016/j.jvs.2025.03.033.Peer-Reviewed Original ResearchAntithrombotic Therapy In Patients With Atrial Fibrillation Undergoing Peripheral Vascular Interventions
Said S, Alameddine D, Aboian E, Strosberg D, Tonnessen B, Cardella J, Guzman R, Chaar C. Antithrombotic Therapy In Patients With Atrial Fibrillation Undergoing Peripheral Vascular Interventions. Annals Of Vascular Surgery 2025, 112: 436-437. DOI: 10.1016/j.avsg.2024.11.070.Peer-Reviewed Original ResearchMidterm outcomes of thoracic endovascular aortic repair versus optimal medical therapy for uncomplicated acute type B dissection
Hu K, Ma W, Pupovac S, Hameed I, Fereydooni S, Li E, Larson H, Zafar M, Tonnessen B, Cardella J, Aboian E, Guzman R, Chaar C, Strosberg D, Williams M, Nassiri N, Assi R, Vallabhajosyula P. Midterm outcomes of thoracic endovascular aortic repair versus optimal medical therapy for uncomplicated acute type B dissection. JTCVS Open 2025, 24: 67-76. PMID: 40309678, PMCID: PMC12039393, DOI: 10.1016/j.xjon.2024.12.013.Peer-Reviewed Original ResearchThoracic endovascular aortic repairThoracic endovascular aortic repair groupOptimal medical therapyOptimal medical therapy groupMidterm outcomes of thoracic endovascular aortic repairOutcomes of thoracic endovascular aortic repairUncomplicated acute type B aortic dissectionEndovascular aortic repairAcute kidney injuryAortic repairMidterm outcomesMedical therapyUncomplicated acute type B dissectionAcute type B aortic dissectionAcute type B dissectionAssociated with improved survivalType B aortic dissectionThirty-day ratesType B dissectionB aortic dissectionPost-operative dataMidterm follow-upIn-hospital/30-day mortalityKaplan-Meier survivalB dissection
2024
Endoscopic Transaxillary First Rib Resection
Setia O, Strosberg D, Blasberg J, Schwartz J, Tonnessen B, Cardella J, Zwibelman H, Guzman R. Endoscopic Transaxillary First Rib Resection. Journal Of Vascular Surgery 2024, 79: e115. DOI: 10.1016/j.jvs.2024.03.139.Peer-Reviewed Original ResearchClinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach
Regan C, Scierka L, Dardik A, Tonnessen B, Chaar C, Ionescu C, Aboian E, Cardella J, Nassiri N, Guzman R, Attaran R, Nagpal S, Shah S, Smolderen K, Mena-Hurtado C. Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach. Vascular 2024, 33: 466-471. PMID: 38669051, DOI: 10.1177/17085381241246318.Peer-Reviewed Original ResearchDual antiplatelet therapyPeripheral arterial diseaseCYP2C19 testingCYP2C19 mutationsHeterogeneity of treatment effectsPeripheral vascular interventionsConsensus statementKnowledge questionsAntiplatelet therapyGenetic testingVascular surgeryAcademic health systemBarriers to implementationInterquartile rangeCYP2C19 genotype testingVascular diseaseInterventional cardiologyModified Delphi methodPatient's metabolic statusManagement of patientsCritical limb ischemiaPerceived barriersPeripheral vascular diseaseArterial vascular diseaseClinician perspectivesRepresentation of female vascular surgeons in national clinical trial leadership: analysis of trends over 20Â years
Kostiuk V, Thaxton C, Loh S, Cardella J, Dardik A, Tonnessen B. Representation of female vascular surgeons in national clinical trial leadership: analysis of trends over 20 years. JVS-Vascular Insights 2024, 2: 100077. DOI: 10.1016/j.jvsvi.2024.100077.Peer-Reviewed Original ResearchClinical trialsFemale vascular surgeonsVascular surgeonsMethods Clinical trialsArtery diseaseClinical trial leadershipSite principal investigatorsVascular conditionsAbdominal aortic aneurysmSurgeon-investigatorInvestigator-led trialsCarotid artery diseasePeripheral arterial diseaseCarotid diseaseProportion of womenVenous thrombectomyBoard certificationAortic aneurysmPercentage of womenIndustry-sponsored trialsTrial leadershipHemodialysis accessSubgroup analysisVascular surgerySurgeons
2022
The Use of Negative Pressure Wound Therapy After Arterial Vascular Reconstructions
Kostiuk V, Setia O, Cardella J, Strosberg D, Tonnessen B, Guzman R, Aboian E. The Use of Negative Pressure Wound Therapy After Arterial Vascular Reconstructions. Journal Of Vascular Surgery 2022, 76: e26-e27. DOI: 10.1016/j.jvs.2022.06.053.Peer-Reviewed Original ResearchIncidence and Characteristics of Deep Venous Reflux in Patients Treated for Superficial Venous Disease with Ablation
Satam K, Aurshina A, Zhuo H, Zhang Y, Cardella J, Aboian E, Tonnessen B, Guzman R, Chaar C. Incidence and Characteristics of Deep Venous Reflux in Patients Treated for Superficial Venous Disease with Ablation. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2022, 10: 568-570. DOI: 10.1016/j.jvsv.2021.12.055.Peer-Reviewed Original Research
2021
Eligibility of Patients With Chronic Limb-Threatening Ischemia for Deep Venous Arterialization Before Amputation
Satam K, Aboian E, Huttler J, Zhuo H, Zhang Y, Tonnessen B, Cardella J, Guzman R, Chaar C. Eligibility of Patients With Chronic Limb-Threatening Ischemia for Deep Venous Arterialization Before Amputation. Journal Of Vascular Surgery 2021, 74: e175. DOI: 10.1016/j.jvs.2021.06.262.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply